Ralfinamide
Ralfinamide is an orally available Na-channel blocker for the treatment of neuropathic pain and other pain conditions. (In Vivo) :Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain.
Product Specifications
CAS Number
133865-88-0
Product Name Alternative
FCE-26742A | Priralfinamide
Purity
>98% (HPLC)
Solubility
DMSO:125 mg/mL (413.44 mM)
Smiles
C[C@H] (NCc1ccc (OCc2ccccc2F) cc1) C (N) =O
Molecular Formula
C17H19FN2O2
Molecular Weight
302.34
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(2S) -2- (4- (2-Fluorobenzyloxy) benzylamino) propanamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1219112-01 0.02 mg (E-Coli)
Recombinant Aeromonas hydrophila subsp. hydrophila Glycine--tRNA ligase alpha subunit (glyQ)
Sign In for Pricing
View Details MBS1219112-02 0.02 mg (Yeast)
Recombinant Aeromonas hydrophila subsp. hydrophila Glycine--tRNA ligase alpha subunit (glyQ)
Sign In for Pricing
View Details MBS1219112-03 0.1 mg (E-Coli)
Recombinant Aeromonas hydrophila subsp. hydrophila Glycine--tRNA ligase alpha subunit (glyQ)
Sign In for Pricing
View Details MBS1219112-04 0.1 mg (Yeast)
Recombinant Aeromonas hydrophila subsp. hydrophila Glycine--tRNA ligase alpha subunit (glyQ)
Sign In for Pricing
View Details MBS1219112-05 0.02 mg (Baculovirus)
Recombinant Aeromonas hydrophila subsp. hydrophila Glycine--tRNA ligase alpha subunit (glyQ)
Sign In for Pricing
View Details MBS1219112-06 0.02 mg (Mammalian-Cell)
Recombinant Aeromonas hydrophila subsp. hydrophila Glycine--tRNA ligase alpha subunit (glyQ)
Sign In for Pricing
View Details